Clinical Trial Update: Minimally Invasive Prostatic Vapor Ablation for the Treatment of BPH in Large Prostates (Rezūm XL) [NA]

View source ↗

Summary

A terminated clinical trial evaluating minimally invasive prostatic vapor ablation (Rezūm XL) for BPH in large prostates; results were posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Rezūm XL

Snippet

Sponsor: Boston Scientific Corporation | Conditions: BPH With Urinary Obstruction, BPH | NA | Status: TERMINATED | Results posted: 2021-08-10